1. Home
  2. AHH vs ABCL Comparison

AHH vs ABCL Comparison

Compare AHH & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHH
  • ABCL
  • Stock Information
  • Founded
  • AHH 1979
  • ABCL 2012
  • Country
  • AHH United States
  • ABCL Canada
  • Employees
  • AHH N/A
  • ABCL N/A
  • Industry
  • AHH Real Estate
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AHH Finance
  • ABCL Health Care
  • Exchange
  • AHH Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • AHH 746.7M
  • ABCL 818.2M
  • IPO Year
  • AHH 2013
  • ABCL 2020
  • Fundamental
  • Price
  • AHH $8.91
  • ABCL $3.03
  • Analyst Decision
  • AHH Buy
  • ABCL Buy
  • Analyst Count
  • AHH 3
  • ABCL 3
  • Target Price
  • AHH $11.58
  • ABCL $8.00
  • AVG Volume (30 Days)
  • AHH 703.8K
  • ABCL 3.9M
  • Earning Date
  • AHH 02-19-2025
  • ABCL 02-27-2025
  • Dividend Yield
  • AHH 9.19%
  • ABCL N/A
  • EPS Growth
  • AHH N/A
  • ABCL N/A
  • EPS
  • AHH 0.33
  • ABCL N/A
  • Revenue
  • AHH $708,715,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • AHH N/A
  • ABCL N/A
  • Revenue Next Year
  • AHH $3.00
  • ABCL $37.26
  • P/E Ratio
  • AHH $27.03
  • ABCL N/A
  • Revenue Growth
  • AHH 6.23
  • ABCL N/A
  • 52 Week Low
  • AHH $8.76
  • ABCL $2.34
  • 52 Week High
  • AHH $12.46
  • ABCL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • AHH 25.92
  • ABCL 45.64
  • Support Level
  • AHH $9.44
  • ABCL $2.88
  • Resistance Level
  • AHH $9.46
  • ABCL $3.60
  • Average True Range (ATR)
  • AHH 0.22
  • ABCL 0.20
  • MACD
  • AHH -0.05
  • ABCL -0.01
  • Stochastic Oscillator
  • AHH 14.85
  • ABCL 20.83

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. They lease our properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting and real estate services. It generates maximum revenue from the general contracting and real estate services segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: